The release of soluble forms of TRAIL and DR5 by neutrophils of oral cavity cancer patients
Abstract: In the present study we examined the release of the soluble form of TRAIL by neutrophils (PMN) derived from patients with oral cavity cancer. Simultaneously, we estimated the ability of PMNs of these patients to release the soluble form of DR5 receptor, a natural regulatory protein of
Deaths from oral cavity and pharyngeal cancer - United States, 1987.
In 1987, more than 9700 deaths in the United States were caused by cancers of the oral cavity and pharynx. Many of these deaths could have been prevented by reduction of personal risk behaviors (e.g., tobacco use and heavy alcohol consumption). This report summarizes epidemiologic data on deaths
DUSA Signs Clinical Trial Agreement With The National Cancer Institute, Division Of Cancer Prevention, For The Clinical Development Of Levulan'R' Pdt For Oral Cavity Dysplasia.
WILMINGTON, Mass. - DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA) today announced the signing of a second clinical trial agreement with the National Cancer Institute (NCI), Division of Cancer Prevention (DCP). The new agreement covers the clinical development of Levulan(R) photodynamic therapy (PDT)
Squamous cell carcinoma of the oral cavity following breast cancer treatment.
To the Editor: Early diagnosis and combined modality of treatment have significantly improved the survival of breast cancer patients. Most patients will die of etiologies other than breast cancer, which may include second primary malignancies (SPM). We report here two patients who developed
Stability of the fluorescence measurement of Foscan in the normal human oral cavity as an indicator of its content in early cancers of the esophagus and the bronchi
ABSTRACT Photodynamic therapy (PDT) with Foscan(R) (mTHPC) is used to cure early cancers of the esophagus or the tracheobronchial tree. However, fixed PDT parameters (drug dose, light dose, etc.) do not permit an accurate prediction of the tissue damage. Large interpatient fluctuations in tissue
Risk for cancer of the pharynx and oral cavity among male painters in the Nordic countries.
The International Agency for Research on Cancer has evaluated occupational exposure to a painter and has concluded that such exposure is carcinogenic to humans, primarily based on findings of consistently elevated risks for lung cancer in epidemiologic studies.[1] Painters are exposed to many
Oral cavity disease: common: cancer of the mouth and various dental disorders are common afflictions. Learn the ways to best protect your cat.
If your normally playful, energetic cat mysteriously starts moping around the house, acting sullen, reclusive, nervous and depressed, chances are that it is trying to cope with some sort of physical discomfort or nagging pain. And it is possible that the source of the poor cat's angst lies
The oral cavity as a test site for photosensitizer level for esophagus and bronchial cancers
Application of PDT for the treatment of early cancers of the esophagus and bronchi requires a good combination of tissular photosensitizer level and light dose at the time of application. The measurement of photosensitizer level is normally done endoscopically at either the esophagus or bronchi
Protocol for the examination of specimens removed from patients with carcinomas of the upper aerodigestive tract: Carcinomas of the oral cavity including lip and tongue, nasal and paranasal sinuses, pharynx, larynx, salivary glands, hypopharynx, oropharynx, and nasopharynx
Carcinomas of the Oral Cavity Including Lip and Tongue, Nasal and Paranasal Sinuses, Pharynx, Larynx, Salivary Glands, Hypopharynx, Oropharynx, and Nasopharynx The Cancer Committee of the College of American Pathologists, as part of its program to ensure quality for anatomic pathology, continues to
Flavonoid Glucosides Are Hydrolyzed and Thus Activated in the Oral Cavity in Humans1,2
ABSTRACT Increasing epidemiological evidence supports the view that dietary flavonoids have protective roles in oral diseases, including cancer. However, the dietary forms of flavonoids, the flavonoid glycosides, must first be hydrolyzed to the aglycones, which is thought to occur mainly in the
